BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37484669)

  • 1. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning.
    Theisen C; Rosen M; Meisenzahl E; Koutsouleris N; Lichtenstein T; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Riecher-Rössler A; Chisholm K; Upthegrove R; Antonucci LA; Bertolino A; Pigoni A; Salokangas RKR; Pantelis C; Wood SJ; Lencer R; Falkai P; Hietala J; Brambilla P; Schmidt A; Andreou C; Borgwardt S; Osman N; Schultze-Lutter F
    Front Psychiatry; 2023; 14():1209485. PubMed ID: 37484669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age effect on prevalence of ultra-high risk for psychosis symptoms: replication in a clinical sample of an early detection of psychosis service.
    Schultze-Lutter F; Hubl D; Schimmelmann BG; Michel C
    Eur Child Adolesc Psychiatry; 2017 Nov; 26(11):1401-1405. PubMed ID: 28456857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.
    Schimmelmann BG; Michel C; Martz-Irngartinger A; Linder C; Schultze-Lutter F
    World Psychiatry; 2015 Jun; 14(2):189-97. PubMed ID: 26043337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders.
    Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Fusar-Poli P; Correll CU
    Front Psychiatry; 2020; 11():568982. PubMed ID: 33192693
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathological characteristics in ultra-high risk for psychosis with and without comorbid ADHD.
    Ribolsi M; Prosperi Porta D; Sacco R; Di Lorenzo G; Fiori Nastro F; Albergo G; Di Lazzaro V; Costa A
    Early Interv Psychiatry; 2024 May; ():. PubMed ID: 38690753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.
    Gaudiano BA; Zimmerman M
    J Clin Psychiatry; 2013 Feb; 74(2):149-55. PubMed ID: 23146173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations.
    Schultze-Lutter F; Renner F; Paruch J; Julkowski D; Klosterkötter J; Ruhrmann S
    Psychopathology; 2014; 47(3):194-201. PubMed ID: 24192655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.
    Mensi MM; Molteni S; Iorio M; Filosi E; Ballante E; Balottin U; Fusar-Poli P; Borgatti R
    Schizophr Bull; 2021 Oct; 47(6):1663-1673. PubMed ID: 33939829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
    Staines L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    BMC Psychiatry; 2021 Jul; 21(1):339. PubMed ID: 34233651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
    Nelson B; Yuen K; Yung AR
    Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.
    Schultze-Lutter F; Walger P; Franscini M; Traber-Walker N; Osman N; Walger H; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2022 Mar; 12(3):425-449. PubMed ID: 35433326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and conversion rate to full psychosis in a prospective cohort study of youth affected by autism spectrum disorder and attenuated psychosis syndrome: A preliminary report.
    Riccioni A; Siracusano M; Vasta M; Ribolsi M; Nastro FF; Gialloreti LE; Di Lorenzo G; Mazzone L
    Front Psychiatry; 2022; 13():950888. PubMed ID: 36213900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age and sex on clinical high-risk for psychosis in the community.
    Schultze-Lutter F; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2020 May; 10(5):101-124. PubMed ID: 32477906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.